Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,091 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Thiotepa/cyclophosphamide/TBI as a conditioning regimen for allogeneic hematopoietic stem cell transplantation in patients aged 50 years and over.
Fujimaki K, Tanaka M, Takasaki H, Hyo R, Kawano T, Sakai R, Fujita H, Fujisawa S, Kanamori H, Maruta A, Ishigatsubo Y. Fujimaki K, et al. Among authors: sakai r. Intern Med. 2008;47(5):379-83. doi: 10.2169/internalmedicine.47.0598. Epub 2008 Mar 3. Intern Med. 2008. PMID: 18310967 Free article. Clinical Trial.
Pretransplant serum ferritin is associated with bloodstream infections within 100 days of allogeneic stem cell transplantation for myeloid malignancies.
Tachibana T, Tanaka M, Takasaki H, Numata A, Ito S, Watanabe R, Hyo R, Ohshima R, Hagihara M, Sakai R, Fujisawa S, Tomita N, Fujita H, Maruta A, Ishigatsubo Y, Kanamori H. Tachibana T, et al. Among authors: sakai r. Int J Hematol. 2011 Mar;93(3):368-374. doi: 10.1007/s12185-011-0784-0. Epub 2011 Feb 18. Int J Hematol. 2011. PMID: 21331523
Clinical significance of minimal residual disease detected by multidimensional flow cytometry: serial monitoring after allogeneic stem cell transplantation for acute leukemia.
Miyazaki T, Fujita H, Fujimaki K, Hosoyama T, Watanabe R, Tachibana T, Fujita A, Matsumoto K, Tanaka M, Koharazawa H, Taguchi J, Tomita N, Sakai R, Fujisawa S, Kanamori H, Ishigatsubo Y. Miyazaki T, et al. Among authors: sakai r. Leuk Res. 2012 Aug;36(8):998-1003. doi: 10.1016/j.leukres.2012.04.005. Epub 2012 Apr 30. Leuk Res. 2012. PMID: 22551655
Validation of the European Group for Blood and Marrow Transplantation (EBMT) risk score in patients receiving allogeneic hematopoietic stem cell transplantation at a single center in Japan.
Numata A, Tanaka M, Matsumoto K, Takasaki H, Tachibana T, Fujimaki K, Sakai R, Fujisawa S, Tomita N, Fujita H, Maruta A, Ishigatsubo Y, Kanamori H. Numata A, et al. Among authors: sakai r. Clin Transplant. 2014 Apr;28(4):403-9. doi: 10.1111/ctr.12324. Epub 2014 Mar 21. Clin Transplant. 2014. PMID: 24655161
Clinical significance of the administration of cytarabine or thiotepa in addition to total body irradiation and cyclophosphamide for allogeneic hematopoietic cell transplantation in patients with acute leukemia.
Tachibana T, Tanaka M, Hagihara M, Kawasaki R, Yamazaki E, Koharazawa H, Taguchi J, Tomita N, Fujimaki K, Sakai R, Fujita H, Fujisawa S, Maruta A, Ishigatsubo Y, Kanamori H. Tachibana T, et al. Among authors: sakai r. Int J Hematol. 2015 Oct;102(4):451-9. doi: 10.1007/s12185-015-1836-7. Epub 2015 Jul 15. Int J Hematol. 2015. PMID: 26173594
Phase II study of CHOP-GR therapy for advanced-stage follicular lymphoma.
Tomita N, Kodama F, Oshima R, Hashimoto C, Koharazawa H, Takemura S, Yamazaki E, Fujimaki K, Sakai R, Fujita H, Fujisawa S, Kanamori H, Motomura S, Ishigatsubo Y. Tomita N, et al. Among authors: sakai r. Leuk Lymphoma. 2006 Jun;47(6):1041-7. doi: 10.1080/10428190500472784. Leuk Lymphoma. 2006. PMID: 16840195 Clinical Trial.
Long-term outcome of L86 and L97 protocols for adult acute lymphoblastic leukemia.
Koharazawa H, Kanamori H, Sakai R, Hashimoto C, Takemura S, Hattori M, Taguchi J, Fujimaki K, Tomita N, Fujita H, Fujisawa S, Harano H, Ogawa K, Motomura S, Maruta A, Ishigatsubo Y. Koharazawa H, et al. Among authors: sakai r. Leuk Lymphoma. 2008 Nov;49(11):2133-40. doi: 10.1080/10428190802464711. Leuk Lymphoma. 2008. PMID: 19021056 Clinical Trial.
1,091 results